142 related articles for article (PubMed ID: 22661194)
1. Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan.
Bienert A; Kamińska A; Olszewski J; Gracz J; Grabowski T; Wolc A; Grześkowiak E
Pharmacol Rep; 2012; 64(2):421-7. PubMed ID: 22661194
[TBL] [Abstract][Full Text] [Related]
2. Influence of the Time of Intravenous Administration of Paracetamol on its Pharmacokinetics and Ocular Disposition in Rabbits.
Karbownik A; Bienert A; Płotek W; Grabowski T; Cerbin-Koczorowska M; Wolc A; Grześkowiak E
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):489-498. PubMed ID: 27485347
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of paracetamol (acetaminophen) and its sulphate and glucuronide metabolites in desert camels and goats.
Ali BH; Cheng Z; el Hadrami G; Bashir AK; McKellar QA
J Vet Pharmacol Ther; 1996 Jun; 19(3):238-44. PubMed ID: 8803883
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery.
Owens KH; Medlicott NJ; Zacharias M; Curran N; Chary S; Thompson-Fawcett M; Reith DM
Ther Drug Monit; 2012 Dec; 34(6):713-21. PubMed ID: 23149443
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravenous paracetamol in elderly patients.
Liukas A; Kuusniemi K; Aantaa R; Virolainen P; Niemi M; Neuvonen PJ; Olkkola KT
Clin Pharmacokinet; 2011 Feb; 50(2):121-9. PubMed ID: 21241071
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic and Quantitative Understanding of Pharmacokinetics in Zebrafish Larvae through Nanoscale Blood Sampling and Metabolite Modeling of Paracetamol.
Van Wijk RC; Krekels EHJ; Kantae V; Ordas A; Kreling T; Harms AC; Hankemeier T; Spaink HP; van der Graaf PH
J Pharmacol Exp Ther; 2019 Oct; 371(1):15-24. PubMed ID: 31371482
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: A potential risk for clinical practice.
Karbownik A; Szałek E; Sobańska K; Grabowski T; Wolc A; Grześkowiak E
Eur J Pharm Sci; 2017 May; 102():55-62. PubMed ID: 28232141
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.
Kulo A; Peeters MY; Allegaert K; Smits A; de Hoon J; Verbesselt R; Lewi L; van de Velde M; Knibbe CA
Br J Clin Pharmacol; 2013 Mar; 75(3):850-60. PubMed ID: 22845052
[TBL] [Abstract][Full Text] [Related]
9. The effect of sunitinib on the plasma exposure of intravenous paracetamol and its major metabolite: paracetamol glucuronide.
Karbownik A; Szałek E; Sobańska K; Połom W; Grabowski T; Biczysko-Murawa A; Matuszewski M; Wolc A; Grześkowiak E
Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):163-70. PubMed ID: 24676873
[TBL] [Abstract][Full Text] [Related]
10. THE EFFECT OF TOTAL AND PARTIAL NEPHRECTOMY ON THE PHARMACOKINETICS OF INTRAVENOUS PARACETAMOL IN HUMANS.
Karbownik A; Polom W; Porazka J; Szalek E; Grabowski T; Wolc A; Matuszewski Marcin ; Grzesowiak E
Acta Pol Pharm; 2017 May; 74(3):929-935. PubMed ID: 29513963
[TBL] [Abstract][Full Text] [Related]
11. Paracetamol and metabolite pharmacokinetics in infants.
van der Marel CD; Anderson BJ; van Lingen RA; Holford NH; Pluim MA; Jansman FG; van den Anker JN; Tibboel D
Eur J Clin Pharmacol; 2003 Jul; 59(3):243-51. PubMed ID: 12761605
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Diabetes Mellitus on Glucuronidation and Sulphation of Paracetamol in Patients with Febrile Neutropenia.
Stachowiak A; Szałek E; Karbownik A; Łojko A; Porażka J; Przewoźna I; Grabowski T; Wolc A; Grześkowiak E
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):289-294. PubMed ID: 30187443
[TBL] [Abstract][Full Text] [Related]
13. Effect of nizatidine on paracetamol and its metabolites in human plasma.
Itoh H; Nagano T; Takeyama M
J Pharm Pharmacol; 2002 Jun; 54(6):869-73. PubMed ID: 12079004
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects.
Flouvat B; Leneveu A; Fitoussi S; Delhotal-Landes B; Gendron A
Int J Clin Pharmacol Ther; 2004 Jan; 42(1):50-7. PubMed ID: 14756388
[TBL] [Abstract][Full Text] [Related]
15. The concomitant use of lapatinib and paracetamol - the risk of interaction.
Karbownik A; Szałek E; Sobańska K; Grabowski T; Klupczynska A; Plewa S; Wolc A; Magiera M; Porażka J; Kokot ZJ; Grześkowiak E
Invest New Drugs; 2018 Oct; 36(5):819-827. PubMed ID: 29464465
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a loading dose of intravenous paracetamol post caesarean delivery.
Kulo A; van de Velde M; de Hoon J; Verbesselt R; Devlieger R; Deprest J; Allegaert K
Int J Obstet Anesth; 2012 Apr; 21(2):125-8. PubMed ID: 22341787
[TBL] [Abstract][Full Text] [Related]
17. Cisapride raises the bioavailability of paracetamol by inhibiting its glucuronidation in man.
Itoh H; Nagano T; Takeyama M
J Pharm Pharmacol; 2001 Jul; 53(7):1041-5. PubMed ID: 11480539
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of single-dose intravenous paracetamol in children.
Mohammed BS; Engelhardt T; Cameron GA; Cameron L; Hawksworth GM; Hawwa AF; McElnay J; Helms PJ; McLay JS
Br J Anaesth; 2012 May; 108(5):823-9. PubMed ID: 22389380
[TBL] [Abstract][Full Text] [Related]
19. Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young women.
Kulo A; Van Calsteren K; van de Velde M; Mulabegovic N; Verbesselt R; de Hoon JN; Verhaeghe J; Allegaert K
Eur Rev Med Pharmacol Sci; 2014; 18(5):599-604. PubMed ID: 24668698
[TBL] [Abstract][Full Text] [Related]
20. Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates.
Allegaert K; Anderson BJ; Naulaers G; de Hoon J; Verbesselt R; Debeer A; Devlieger H; Tibboel D
Eur J Clin Pharmacol; 2004 May; 60(3):191-7. PubMed ID: 15071761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
